4ª Edição

Paper presented at SABCS 2019 evaluated the new antibody-drug conjugate trastuzumab-deruxtecan in breast cancer patients previously treated with T-DM1

per: Grupo Oncoclínicas
Paper presented at SABCS 2019 evaluated the new antibody-drug conjugate trastuzumab-deruxtecan in breast cancer patients previously treated with T-DM1

Scientific commission

Aline Gonçalves
Aline Gonçalves
Bruno Ferrari
Bruno Ferrari
Carlos Barrios
Carlos Barrios
Daniel Gimenes
Daniel Gimenes

Contributors

Cristiano Augusto Andrade de Resende
Cristiano Augusto Andrade de Resende
Tomás Reinert
Tomás Reinert

This is a scientific newsletter curated by the main medical-scientific content for each specialty and interdisciplinary work between oncology and other areas. Enjoy your reading!

Access the full article of this study
Download
Share
Or share the link
Link copied to your desktop.L